Coripharma ehf. Genericon Pharma Gesellschaft m.b.H.
PolandAll drugs from this manufacturer
-
The medicine is used in adults as well as children and adolescents (over 10 years of age) for the treatment of relapsing-remitting multiple sclerosis (MS), particularly in individuals for whom treatment is ineffective or in whom the disease is progressing rapidly and severely.
Dosage form: capsules, hard
Active substance Dosage fingolimod 0.5 mg ATC: L04AE01